Suggest a term for the new Regenerative Medicine glossary!

In preparation for publishing the fourth edition of the Regenerative Medicine glossary, we need you to help suggest what new terms we should include.

Go to the profile of Regenerative Medicine
May 17, 2018
0
0
Upvote 0 Comment

The Regenerative Medicine Cell Therapy and Regenerative Medicine Glossary can be found in offices and labs worldwide, and is currently in its third edition.

Read the 3rd edition of the glossary

In 2019, to recognize 2 years since the 3rd edition was release, we will be publishing the new, updated fourth edition; however, we need your help. In the last 2 years, the cell therapy and regenerative medicine industry has expanded rapidly, and we want you to help us decide which new terms to include.

Create your own user feedback survey

Go to the profile of Regenerative Medicine

Regenerative Medicine

Journal, Future Science Group

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Emcare, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Journal Citation Reports/Science Edition®, Scopus® with an Impact Factor of 2.786 (2014). Each issue contains expertly drafted Reviews, Original Research articles, Perspectives, Editorials, topical insight from international leaders in their field, and additional added-value content. The Senior Editor of the journal is Professor Chris Mason, University College London. You can find out more about Regenerative Medicine at our website (www.future-science-group.com/journalprofile/regenerative-medicine/), where you can find the aims and scope of the journal and details of our international editorial board.

No comments yet.